Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"A Multi-Centre, Randomized, Double Blind, Parallel-Group, Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Generic Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) to Clotrimazole Troche/Lozenges ® 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis ".

NCT02635438 is registered in ClinicalTrials.gov with Thinq Pharma-CRO Pte. Ltd. as lead sponsor.

NCT NCT02635438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02635438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"A Multi-Centre, Randomized, Double Blind, Parallel-Group, Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Generic Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) to Clotrimazole Troche/Lozenges ® 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis ".
Lead sponsor
Thinq Pharma-CRO Pte. Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2016
Completion date
November 30, 2018
Enrollment
360 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

oropharyngeal candidiasis